Georgia Mesothelioma Doctors, Cancer Centers and Treatment

Mesothelioma patients who live in Georgia have access to quality mesothelioma treatment options in state. Conventional mesothelioma treatments available in Georgia include surgery, chemotherapy and radiation. Beyond these conventional treatments, clinical trials may currently be recruiting pleural and peritoneal mesothelioma patients in Georgia.

We provide a list of top mesothelioma doctors that practice in Georgia as well as the top cancer care centers in the state. A list of local cancer support services has been included as well for your convenience. Learn more about health care options available to you in Georgia here.

Find a Mesothelioma Cancer Center in Georgia

We have compiled a list of mesothelioma cancer centers in Georgia. Please click on a cancer center link for more information about the clinical programs offered, affiliated mesothelioma doctors and how to contact the cancer center.

Doctors who Treat Mesothelioma in Georgia

We have compiled a list of mesothelioma doctors that practice in the state of Georgia. Please click on a doctor link to obtain more information about his/her background, areas of expertise, professional affiliations, and office locations.

Occasionally, mesothelioma patients will travel to other states to meet with top mesothelioma doctors and thoracic surgeons across the country. These experts will usually concentrate on a particular mesothelioma type within their practice.

Mesothelioma Clinical Trials in Georgia

The following clinical trials are in progress or actively recruiting participants in the state of Georgia:

• Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

  Conditions:	Acinar Cell Carcinoma; Adenoid Cystic Carcinoma; Adrenal Cortex Carcinoma; Adrenal Gland Pheochromocytoma; Anal Canal Neuroendocrine Carcinoma; Anal Canal Undifferentiated Carcinoma; Angiosarcoma; Apocrine Neoplasm; Appendix Mucinous Adenocarcinoma; Bartholin Gland Transitional Cell Carcinoma; Basal Cell Carcinoma; Bladder Adenocarcinoma; Cervical Adenocarcinoma; Cervical Clear Cell Adenocarcinoma; Cholangiocarcinoma; Chordoma; Colorectal Squamous Cell Carcinoma; Desmoid-Type Fibromatosis; Endometrial Transitional Cell Carcinoma; Endometrioid Adenocarcinoma; Esophageal Neuroendocrine Carcinoma; Esophageal Undifferentiated Carcinoma; Extrahepatic Bile Duct Carcinoma; Extramammary Paget Disease; Fallopian Tube Adenocarcinoma; Fallopian Tube Transitional Cell Carcinoma; Fibromyxoid Tumor; Gallbladder Carcinoma; Gastric Neuroendocrine Carcinoma; Gastric Squamous Cell Carcinoma; Gastric Undifferentiated Carcinoma; Gastrointestinal Stromal Tumor; Gestational Trophoblastic Tumor; Giant Cell Carcinoma; Intestinal Neuroendocrine Carcinoma; Intrahepatic Cholangiocarcinoma; Lung Carcinoid Tumor; Lung Sarcomatoid Carcinoma; Major Salivary Gland Carcinoma; Malignant Odontogenic Neoplasm; Malignant Peripheral Nerve Sheath Tumor; Malignant Testicular Sex Cord-Stromal Tumor; Metaplastic Breast Carcinoma; Metastatic Malignant Neoplasm of Unknown Primary; Minimally Invasive Lung Adenocarcinoma; Mixed Mesodermal (Mullerian) Tumor; Mucinous Adenocarcinoma; Mucinous Cystadenocarcinoma; Nasal Cavity Adenocarcinoma; Nasal Cavity Carcinoma; Nasopharyngeal Carcinoma; Nasopharyngeal Papillary Adenocarcinoma; Nasopharyngeal Undifferentiated Carcinoma; Oral Cavity Carcinoma; Oropharyngeal Undifferentiated Carcinoma; Ovarian Adenocarcinoma; Ovarian Clear Cell Adenocarcinoma; Ovarian Germ Cell Tumor; Ovarian Mucinous Adenocarcinoma; Ovarian Squamous Cell Carcinoma; Ovarian Transitional Cell Carcinoma; Pancreatic Acinar Cell Carcinoma; Pancreatic Neuroendocrine Carcinoma; Paraganglioma; Paranasal Sinus Adenocarcinoma; Paranasal Sinus Carcinoma; Parathyroid Gland Carcinoma; PEComa; Peritoneal Mesothelioma; Pituitary Gland Carcinoma; Placental Choriocarcinoma; Primary Peritoneal High Grade Serous Adenocarcinoma; Pseudomyxoma Peritonei; Rare Disorder; Scrotal Squamous Cell Carcinoma; Seminal Vesicle Adenocarcinoma; Seminoma; Serous Cystadenocarcinoma; Small Intestinal Adenocarcinoma; Small Intestinal Squamous Cell Carcinoma; Solid Neoplasm; Spindle Cell Neoplasm; Squamous Cell Carcinoma of the Penis; Teratoma With Somatic-Type Malignancy; Testicular Non-Seminomatous Germ Cell Tumor; Thyroid Gland Carcinoma; Tracheal Carcinoma; Transitional Cell Carcinoma; Ureter Adenocarcinoma; Ureter Squamous Cell Carcinoma; Urethral Adenocarcinoma; Urethral Squamous Cell Carcinoma; Vaginal Adenocarcinoma; Vaginal Squamous Cell Carcinoma, Not Otherwise Specified; Vulvar Carcinoma
  Last Updated:	July 8, 2019
  Status:	Recruiting
  Locations:	Atlanta, GA. Columbus, GA. Decatur, GA. Fayetteville, GA. Rome, GA. Savannah, GA. Birmingham, AL. Mobile, AL. Anchorage, AK. Fairbanks, AK.

• Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma

  Conditions:	Unresectable Pleural or Peritoneal Malignant Mesothelioma
  Last Updated:	July 2, 2019
  Status:	Active, not recruiting
  Locations:	Augusta, GA. Scottsdale, AZ. La Jolla, CA. Los Angeles, CA. San Francisco, CA. Santa Monica, CA. New Haven, CT. Newark, DE. Tampa, FL. Chicago, IL.

• Phase II MEDI4736 in Combination With Chemotherapy for First-Line Treatment of Unresectable Mesothelioma

  Conditions:	Mesothelioma; Pleural Mesothelioma
  Last Updated:	June 17, 2019
  Status:	Active, not recruiting
  Locations:	Atlanta, GA. La Jolla, CA. Los Angeles, CA. Stanford, CA. Aurora, CO. Miami, FL. Chicago, IL. Evanston, IL. Baltimore, MD. Ann Arbor, MI.

• A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

  Conditions:	Melanoma; Breast Carcinoma; Hepatocellular Carcinoma; Urothelial Carcinoma; Squamous Cell Carcinoma of the Head and Neck; Renal Cell Carcinoma; Colorectal Carcinoma; Non-small Cell Lung Carcinoma; Gastric or Gastroesophageal Junction Adenocarcinoma; Endometrial Carcinoma; Mesothelioma; Neuroendocrine Carcinoma; Cervical Cancer; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of the Anus
  Last Updated:	April 29, 2019
  Status:	Recruiting
  Locations:	Atlanta, GA. Los Angeles, CA. San Diego, CA. San Francisco, CA. Chicago, IL. Fairway, KS. Detroit, MI. New York, NY. Portland, OR. Philadelphia, PA.

• Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma

  Conditions:	Epithelioid Mesothelioma; Pleural Malignant Mesothelioma; Recurrent Malignant Mesothelioma; Sarcomatoid Mesothelioma
  Last Updated:	January 16, 2019
  Status:	Active, not recruiting
  Locations:	Gainesville, GA. Rogers, AR. Antioch, CA. Burbank, CA. Fremont, CA. Fresno, CA. Los Angeles, CA. Modesto, CA. Oakland, CA. Orange, CA.

Locate Cancer Support Services in Georgia

Cancer support services for mesothelioma patients include patient transport, temporary housing, physical therapy and counseling. The following local services may be of help to you while you are receiving treatment for mesothelioma in Georgia.

Financial Assistance Available for Mesothelioma Victims

Help provide security for loved ones.